These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6124726)

  • 21. A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.
    Erwa HH; Haseeb MA; Idris AA; Lapeyssonnie L; Sanborn WR; Sippel JE
    Bull World Health Organ; 1973; 49(3):301-5. PubMed ID: 4211056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].
    Spiegel A; Greindl Y; Lippeveld T; Decam C; Granga D; Nahor N; Bordonado JL; Sperber G; Yankalbe M; Baudon D
    Bull World Health Organ; 1993; 71(3-4):311-5. PubMed ID: 8324849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [African aspects of vaccination in prevention of purulent meningitis].
    Rey M
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):237-52. PubMed ID: 6788000
    [No Abstract]   [Full Text] [Related]  

  • 25. Meningitis in Chad, Niger and Nigeria: 2009 epidemic season.
    Wkly Epidemiol Rec; 2010 Feb; 85(8):47-63. PubMed ID: 20210043
    [No Abstract]   [Full Text] [Related]  

  • 26. Meningococcal immunisation and protection from epidemics.
    Hassan J; Massougbodji A; Chippaux JP; Massit B; Josse R
    Lancet; 1998 Aug; 352(9125):407-8. PubMed ID: 9717959
    [No Abstract]   [Full Text] [Related]  

  • 27. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
    Robbins JB; Towne DW; Gotschlich EC; Schneerson R
    Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
    García Moreno J; Prat Miranda MS; Vicent P; Calderón B
    Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outbreak of group C meningococcal disease in Australian Aboriginal children.
    Holmes W
    Lancet; 1995 Aug; 346(8974):573-4. PubMed ID: 7658794
    [No Abstract]   [Full Text] [Related]  

  • 31. A vaccine to prevent epidemic meningitis in Africa.
    Greenwood B; Stuart JM
    Lancet Infect Dis; 2012 Oct; 12(10):738-9. PubMed ID: 22818242
    [No Abstract]   [Full Text] [Related]  

  • 32. Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci.
    Mäkelä PH; Peltola H
    Lancet; 1978 Oct; 2(8093):780-1. PubMed ID: 80699
    [No Abstract]   [Full Text] [Related]  

  • 33. Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination.
    Biselli R; Fattorossi A; Matricardi PM; Nisini R; Stroffolini T; D'Amelio R
    Vaccine; 1993; 11(5):578-81. PubMed ID: 8488715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manson Lecture. Meningococcal meningitis in Africa.
    Greenwood B
    Trans R Soc Trop Med Hyg; 1999; 93(4):341-53. PubMed ID: 10674069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune response to meningococci].
    Flaegstad T
    Tidsskr Nor Laegeforen; 1989 Jan; 109(1):33-6. PubMed ID: 2492123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine.
    LaForce FM; Okwo-Bele JM
    Health Aff (Millwood); 2011 Jun; 30(6):1049-57. PubMed ID: 21653956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic.
    Kriz P; Vlckova J; Bobak M
    Epidemiol Infect; 1995 Dec; 115(3):411-8. PubMed ID: 8557072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to epidemic meningitis in Africa, 1997.
    Wkly Epidemiol Rec; 1997 Oct; 72(42):313-8. PubMed ID: 9347699
    [No Abstract]   [Full Text] [Related]  

  • 39. Protective efficacy of a bivalent (A + C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda.
    Bosmans E; Vimont-Vicary P; Andre FE; Crooy PJ; Roelants P; Vandepitte J
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):297-306. PubMed ID: 6788001
    [No Abstract]   [Full Text] [Related]  

  • 40. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.